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One possible explanation of the commonly reported associations between early onset
cannabis use and elevated risks of other illicit drug use is that early onset cannabis use
increases access and availability to other drugs. It was this argument that in part motivated
policy changes in the Netherlands that led to the de facto legalization of cannabis there. This
study examines, using a co-twin control design, whether previously observed associ- ations
between early onset cannabis use and elevated lifetime rates of other illicit drug use would
also be observed in a sample of 219 same sex Dutch twin pairs discordant for cannabis use
before age 18. After adjustment for covariates, rates of lifetime party drug use (OR=7.4,
95% CI=2.3–23.4), hard drug use (OR=16.5, 95% CI=2.4–111.3), but not regular
cannabis use (OR=1.3, 95% CI=0.3–5.1) were signiﬁcantly elevated in individuals who
reported early onset cannabis use, relative to their co-twin who had not used cannabis by
age 18. The elevated odds of subsequent illicit drug use in early cannabis users relative to
their non early using cotwins suggests that this association could not be explained by
common familial risk factors, either genetic or environmental, for which our co-twin
methodology provided rigorous control.
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One of the most enduring controversies in drug
research and policy concerns the extent to which
early cannabis use may predispose to the use of
other ‘‘hard’’ drugs such as cocaine and heroin
(Kleiman, 1992; MacCoun, 1998). Stage theory
posits that there is an invariant sequence in drug
use with onset of use falling along a continuum
with the licit drugs (tobacco, alcohol) being used
before cannabis, which in turn precedes the use of
other drugs such as cocaine and heroin (Kandel,
1975; Kandel and Faust, 1975). While such a
sequence has been observed in numerous studies
(Collins, 2002; Ellickson et al., 1992; Graham et al.,
1991; Kandel et al., 1992; Kandel and Yamaguchi,
2002), the interpretation of such ﬁndings remains
controversial. Speciﬁcally, some researchers have
argued that cannabis plays a causal role in the
escalation to other drug use and that therefore
delay or avoidance of cannabis use would reduce –
or even eliminate – risks of the subsequent use of
other drugs (DeWit et al., 2000; Kosterman et al.,
2000). Conversely, it has been argued that the
observed associations may simply reﬂect a combi-
nation of common underlying vulnerabilities to
substance use in general (Baumrind, 1983; Morral
et al., 2002) and levels of availability and access to
diﬀerent drug classes (Wagner and Anthony, 2002;
Wilcox et al., 2002). Controversy surrounding this
issue is not solely of academic interest: the alleged
gateway eﬀects of cannabis have been used as a
major rationale for the continued legal prohibition
of that drug in the US and many other countries.
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Tests of this hypothesis require that patterns of
other drug use be compared in people who differ in
no respects other than their use of cannabis. Several
studies have attempted to achieve such control using
statistical adjustments and have reported that early
cannabis use remains a risk factor for the subsequent
use of other drugs (Fergusson and Horwood, 1997,
2000; Yamaguchi and Kandel, 1984). Similarly, we
recently reported analyses using a genetically infor-
mative design comparing rates of other drug use and
drug abuse/dependence in Australian twin pairs dis-
cordant for early cannabis use (before the age of
17 years;. Lynskey et al., 2003). Such a design pro-
vides a rigorous test of the hypothesis that early
cannabis use inﬂuences risks of later drug use and
drug/abuse dependence as, for twin pairs raised to-
gether, as was our Australian sample, aspects of the
home and family environment do not diﬀer and, in
the case of monozygotic twins, members of each pair
are genetically identical. Thus comparisons within
twin pairs are likely to achieve a more rigorous
control of potentially confounding covariates than
reliance on statistical control of observed covariates
assessed in non-related individuals. Our results indi-
cated that individuals who used cannabis by age 17
had odds of other drug use and drug abuse/depen-
dence that were 2.1–5.2 times higher than those of
their co-twin who did not use cannabis before age 17.
There are a number of possible mechanisms that
may underlie this observed association. Firstly, re-
search indicates that D9 – tetrahydrocannabinol and
heroin have similar effects on dopamine transmission
through a common l1 opioid receptor mechanism
(Tanda et al., 1997) and that chronic treatment with
D9 – tetrahydrocannabinol induces cross-tolerance to
amphetamine (Lamarque et al., 2001) and opioids
(Cadoni et al., 2001; Lamarque et al., 2001) in rats.
However, it is unlikely that biological mechanisms
could plausibly explain the observed associations as
the extent of cannabis use among young people is
typically quite low and infrequent, and is certainly
substantially lower than the equivalent doses used in
animal research. Alternatively, it is possible that the
mechanisms underlying the observed association are
largely social in nature. In particular, it has been
argued that early access to cannabis may provide
heightened access to and exposure to other illicit
drugs. Indeed, it was this argument that provided the
impetus for the Netherlands to eﬀectively decrimi-
nalize cannabis use in the 1970s in an attempt to
separate the cannabis and ‘‘hard’’ drug markets.
Thus, if the factors underlying the observed
associations between early onset cannabis use and
subsequent use of other illicit drugs arise principally
from the legal status of cannabis, with early access to
cannabis being associated with increased access to
other illicit drugs, it would be hypothesized that the
association between early onset cannabis use and the
use of other illicit drugs would reduce or disappear in
societies such as the Netherlands where cannabis is
readily available while other drugs remain illegal.
As a test of this hypothesis, therefore, it is of
interest to explore whether the effects observed in our
Australian sample of twins would also be observed in
a sample from the Netherlands. Accordingly, the
aims of this paper are to use a discordant twin design
to compare rates of other illicit drug use in individ-
uals reporting early onset cannabis use and their co-
twins who did not use cannabis at an early age.
METHOD
Sample
The data presented in this paper are part of an
ongoing twin family study on health-related behavior
of the Netherlands Twin Register (NTR) that assesses
families with adolescent and young adult twins every
2/3 years since 1991 (Boomsma et al., 2002). For the
present study, the data from the 1995 and the 2000
surveys were used. In 1995, 3415 twins participated in
the study and 4610 twins completed the 2000 survey.
The total sample contained 6228 twins and 1800
twins participated in both waves. Average age at
most recent interview was 26.75 years (SD 11.8).
While there was wide variation in the age range of the
sample, almost 75% of the sample was born between
1965 and 1980.
Measures
Cannabis Use
Lifetime use of cannabis was reported by 21.6%
of the sample. Self-report data on age of ﬁrst can-
nabis use from waves 3 to 5 were combined so that an
individual who reported early onset cannabis use
(before age 18) at either wave 3 or wave 5 was clas-
siﬁed as an early onset user: 12.5% (544) reported
initiating cannabis use before the age of 18 years. Of
these, 219 (40.3%) were from same-sex twin pairs in
which their twin did not report having used cannabis
by the age of 18 and it is this subsample of discordant
twins that is included in the current analysis. Oppo-
site sex twins discordant for early onset cannabis use
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were excluded from the current analyses because
documented sex differences in the prevalence of illicit
drug use suggest that sex may be one important fac-
tor associated with both early onset cannabis use and
subsequent illicit drug use: comparison of rates of
illicit drug use in opposite sex twins would therefore
not control for this potentially important source of
confounding. The ﬁnal sample comprised 45 MZ
male twin pairs; 63 DZ male twin pairs; 65 MZ fe-
male twin pairs and 46 DZ female twin pairs.
Other Drug Use
Lifetime drug use was assessed for the following
drug classes: party drugs (reported by 3.3% of the
analysis sample) and hard drugs (reported by 2.3% of
the analysis sample). As for the assessment of early
onset cannabis use, an individual reporting any life-
time use of party or hard drugs at either waves 3 or 5
was classiﬁed as having used these drugs.
Regular Cannabis and Other Illicit Drug Use
In addition to reports of any lifetime use, 3.6%
of the analyzed sample reported regular use of can-
nabis and this measure was included as an outcome in
the current analyses. Regular use of both party drugs
and hard drugs was also assessed. However, such use
was reported only by those who had used cannabis by
age 18 years. Given this, these outcomes were ex-
cluded from the current analyses. Of course, it could
be argued that the fact that only those who had used
cannabis before age 18 reported regular use of both
types of drugs provides compelling support for the
hypothesis that early cannabis use inﬂuences risks of
subsequent regular drug use.
Observed Covariates
To further control the associations between early
cannabis use and subsequent illicit drug use a range
of measures of early substance use and rule breaking
behavior were included in the analyses. These mea-
sures were:
1. Regular tobacco use before age 18.
2. Regular alcohol use before age 18.
3. Aggressive behavior assessed in wave 5 using
subscales of the Young Adult Self Report (YASR;
Achenbach, 1997), translated into Dutch and
validated by Verhulst et al. (1997).
4. Rule breaking behavior, again assessed at wave 5
using subscales of the Young Adult Self Report
(YASR; Achenbach, 1997), translated into Dutch
and validated by Verhulst et al. (1997).
Statistical Analyses
All statistical analyses were conducted using
SAS (SAS Institute, 1996) and Stata (StataCorp,
1999). Conditional logistic regression models were
ﬁtted to test for excess risk among early onset can-
nabis users from discordant pairs, compared to their
co-twin controls. Data from unlike-sex pairs and
singletons were excluded. The signiﬁcance of the
interactions between early cannabis use and both
twin pair zygosity and gender were tested and, as
these were non-signiﬁcant, data were pooled across
zygosity, and across gender. Analyses were repeated
including the covariate factors described above (early
tobacco and alcohol use, aggressive and rule breaking
behavior). Stepwise regression with backward selec-
tion was conducted with the measure of early can-
nabis use forced into the model. These analyses were
used to estimate conditional odds ratios for hard
drug use, party drug use and regular cannabis use in
twins discordant for early cannabis use after control
for other signiﬁcant predictors.
RESULTS
The ﬁrst two columns of Table I show estimates
of the lifetime prevalence (%) of party drug use, hard
drug use and regular cannabis use for those initiating
cannabis use before age 18 and for their co-twins (who
either reported no lifetime cannabis use or who re-
ported initiating cannabis use at age 18 or older). The
table also shows that, before adjustment for covari-
ates, odds of party drug use (OR=6.8, 95% CI=2.7–
17.4) hard drug use (OR=14.0, 95% CI=3.3–58.8)
party and/or hard drug use (OR=6.3, 95% CI=2.7–
15.0) and regular cannabis use (OR=4.7, 95%
CI=2.1–10.7) were signiﬁcantly higher in those who
used cannabis before age 18 than in their co-twins who
did not report early cannabis use. However, after
adjustment for covariates (principally other early
onset substance use and rule breaking behavior) there
was no signiﬁcant association (OR=1.3, 95%
CI=0.3–5.1) between early cannabis use and later
risks of regular cannabis use, although signiﬁcant
associations remained between early onset cannabis
use and the use of party and/or hard drugs.
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Although not shown in the table, early onset of
cannabis use was also associated with elevated rates
of regular party drug use and regular hard drug use:
6.4% of early cannabis users reported regular party
drug use and 5.1% reported regular use of hard drugs
while none of their co-twins reported such use.
DISCUSSION
The results of our study indicated that young
people who initiated cannabis use before age 18 were
at heightened risk for the subsequent use of other
drugs, relative to their co-twin who did not initiate
cannabis use before age 18. Notably, while 5.1–6.4%
of early cannabis users reported regular use of party
or hard drugs, none of their co-twins reported such
use. Our use of the co-twin control methodology
provides a powerful methodology for controlling for
the effects of potentially confounding familial factors
that may act to predispose young people both to early
cannabis use and to the subsequent use of other illicit
drugs. While traditional research designs typically
attempt to control for such sources of confounding
through statistical control of observed covariates, we
believe that the co-twin control methodology pro-
vides more stringent control for familial sources of
confounding. This is especially true among dis-
cordant MZ twin pairs, who comprised fully half of
our sample.
There are several caveats that need to be con-
sidered when interpreting these results. Firstly, the
observation that familial factors do not entirely ex-
plain the association between early cannabis use and
subsequent cannabis use, while suggesting a potential
causal role for cannabis use in the development of
other illicit drug use, does not prove such as an
association. Speciﬁcally, there may be other factors,
especially aspects of the non shared environment
(e.g., peer afﬁliations) preceding the onset of cannabis
use that might account for the observed associations.
Secondly, it remains possible that early onset
cannabis use may be associated not with an increased
risk for lifetime illicit drug use but with an earlier
onset of such use. While possible, we consider this
unlikely as the average age of the sample exceeds the
period of maximum risk for the initiation of drug use.
Finally, our study results rely critically on self report
data and it is possible that such reports may be biased
in some way. Nonetheless, the available research
evidence supports the use of self-reported age of onset
of cannabis use as these reports have been shown to
have acceptable reliability and validity (Cottler et al.,
1989; Grant et al., 1995) and that age at which sub-
stance use was assessed did not moderate the asso-
ciations between age-of-onset and substance use
related outcomes (Parra et al., 2003).
Our results parallel earlier ﬁndings from an
Australian sample (Lynskey et al., 2003) and suggest
that observed associations between early cannabis use
and later drug use are unlikely to be due to the eﬀects
of familial factors predisposing to both early canna-
bis use and to the use of other illicit drugs. Further-
more, our replication of the previous results in a
society in which legal sanctions against the use of
cannabis are not applied suggests that these associa-
tions are not solely due to legal factors surrounding
the context in which cannabis is used and obtained.
They do not, however, discount social mechanisms as
the mechanisms underlying these associations. Spe-
ciﬁcally, despite the liberal approach to cannabis use
in the Netherlands, rates of cannabis use are sub-
stantially lower in that country than in Australia, the
US and many other countries. For example, a recent
study comparing rates of drug use in seven countries
(Vega et al., 2002) noted that the lifetime rate of
cannabis use in the Netherlands (12.3%) was less
than half of that in the US (28.8%) while a compa-
rable estimate for Australia is that 39.3% of the adult
population have used cannabis (Australian Institute
of Health and Welfare, 1999). Thus, cannabis use
Table I. Drug Use Outcomes in Twin Pairs Discordant for Cannabis Use before Age 18 (234 pairs)
Lifetime prevalence Odds ratios (95% CI)
Early cannabis users (%) Co-twins (%) Unadjusted Adjusted Signiﬁcant covariatesa
Use
Party drugs 16.2 3.8 6.8 (2.7–17.4) 7.4 (2.3–23.4) 1
Hard drugs 12.8 1.7 14.0 (3.3–58.8) 16.5 (2.4–111.3) 1
Any party/Hard drug use 17.9 4.3 6.3 (2.7–15.0) 6.5 (2.4–17.9) 1
Regular use
Cannabis 16.2 5.1 4.7 (2.1–10.6) 1.3 (.3–5.1) 1,2
aSigniﬁcant covariates: 1=rule breaking behavior (wave 5); 2=early regular tobacco use.
198 Lynskey, Vink, and Boomsma
may represent a norm-violating and unconventional
behavior in the Netherlands in much the same way as
it does in Australia and other countries that adopt
more punitive legal approached to cannabis.
The results of this study hopefully will reduce the
controversy surrounding the inﬂuence of early can-
nabis use on the subsequent use of other drugs.
Irrespective of the causal process assigned to the
observed effects, it is apparent that young people who
initiate cannabis use at an early age are at heightened
risks for the use of other drugs and the development
of drug abuse/dependence. Interventions could
therefore be usefully targeted at such individuals in
an attempt to decrease the risks that they will pro-
gress to the use of other drugs and or drug abuse/
dependence.
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